Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic Recurrence
Clinical trial NCT03694249 · UNKNOWN
Trial details
- NCT number
- NCT03694249
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-12
- Primary completion
- 2025-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.